Cargando…

Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy

The higher immunogenicity of tumors usually predicts favorable therapeutic responses. Tumor antigens dominate the immunogenic character within tumors. We investigated if there was a targetable tumor antigen during immunogenic chemotherapy within lung cancer. Chemotherapy-induced immunogenic senescen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Defeng, Zheng, Xiaohu, Du, Xianghui, Wang, Dong, Hu, Ziming, Sun, Rui, Tian, Zhigang, Fu, Binqing, Wei, Haiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123058/ https://www.ncbi.nlm.nih.gov/pubmed/34674012 http://dx.doi.org/10.1007/s00262-021-03077-1

Ejemplares similares

LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer
por: Hu, Ziming, et al.
Publicado: (2020)

Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer
por: Cheng, Min, et al.
Publicado: (2008)

Human-Induced CD49a(+) NK Cells Promote Fetal Growth
por: Du, Xianghui, et al.
Publicado: (2022)

Tumor-infiltrating platelets promote the growth of lung adenocarcinoma
por: Li, Xiaohui, et al.
Publicado: (2023)

Rapamycin Pretreatment Rescues the Bone Marrow AML Cell Elimination Capacity of CAR-T Cells
por: Nian, Zhigang, et al.
Publicado: (2021)

LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia
por: Wang, Dong, et al.
Publicado: (2023)

mRNA expression of CK19, EGFR and LUNX in patients with lung cancer micrometastasis
por: ZHANG, XIANSEN, et al.
Publicado: (2014)

Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling
por: Wang, Dongyao, et al.
Publicado: (2019)

Lung specific X protein as a novel therapeutic target for lung cancer
por: Zheng, Xiaohu, et al.
Publicado: (2015)

CD11b(−)CD27(−) NK Cells Are Associated with the Progression of Lung Carcinoma
por: Jin, Jing, et al.
Publicado: (2013)

Programmed differentiated natural killer cells kill leukemia cells by engaging SLAM family receptors
por: Wu, Yang, et al.
Publicado: (2017)

Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma
por: Tang, Ying, et al.
Publicado: (2013)

Interactions between driver genes shape the signaling pathway landscape and direct hepatocellular carcinoma therapy
por: Shen, Yiqing, et al.
Publicado: (2023)

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
por: Zhou, Yonggang, et al.
Publicado: (2020)

Cytokine-Based Generation of CD49a(+)Eomes(−/+) Natural Killer Cell Subsets
por: Ni, Xiang, et al.
Publicado: (2018)

Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer
por: Zhang, Xin, et al.
Publicado: (2020)

TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence
por: Sun, Cheng, et al.
Publicado: (2012)

IGF-1 promotes the development and cytotoxic activity of human NK cells
por: Ni, Fang, et al.
Publicado: (2013)

Influenza Vaccine Induces Intracellular Immune Memory of Human NK Cells
por: Dou, Yaling, et al.
Publicado: (2015)

A long noncoding RNA positively regulates CD56 in human natural killer cells
por: Zhang, Ruya, et al.
Publicado: (2016)

Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy
por: Yue, Ting, et al.
Publicado: (2016)

Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients
por: Jin, Linlin, et al.
Publicado: (2021)

MicroRNA transcriptomes of distinct human NK cell populations identify miR-362-5p as an essential regulator of NK cell function
por: Ni, Fang, et al.
Publicado: (2015)

NKp30(+) NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B
por: Shen, Xiaokun, et al.
Publicado: (2016)

Low-dose immunogenic chemotherapeutics promotes immune checkpoint blockade in microsatellite stability colon cancer
por: Fang, Yuhang, et al.
Publicado: (2022)

Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
por: Lin, Weihao, et al.
Publicado: (2021)

Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma
por: Jiang, Yong, et al.
Publicado: (2019)

KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis B
por: Li, Wenting, et al.
Publicado: (2017)

Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24(+)CD38(hi) B Cells
por: Fu, Binqing, et al.
Publicado: (2020)

Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm
por: Zhang, Jinghe, et al.
Publicado: (2021)

Why tocilizumab could be an effective treatment for severe COVID-19?
por: Fu, Binqing, et al.
Publicado: (2020)

Advances in Immunotherapy for Hepatitis B
por: Wang, Dongyao, et al.
Publicado: (2022)

GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT
por: Wang, Dongyao, et al.
Publicado: (2022)

IL-6 modulation for COVID-19: the right patients at the right time?
por: Ascierto, Paolo Antonio, et al.
Publicado: (2021)

CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients
por: Guo, Chuang, et al.
Publicado: (2016)

Restoration of HBV-specific CD8(+) T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy
por: Wang, Dongyao, et al.
Publicado: (2021)

Transcriptomic characteristics and impaired immune function of patients who retest positive for SARS-CoV-2 RNA
por: Wang, Dongyao, et al.
Publicado: (2021)

Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
por: Marin, Ines, et al.
Publicado: (2023)

Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients
por: Rehulkova, Alona, et al.
Publicado: (2023)

Organ-Specific Immune-Related Adverse Events for PD-1 Antibodies in Lung Cancer Treatment
por: Zheng, Xiaohu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e14f2t9aql9rofk9s1oogjm2v3